Retrospective Analysis for the ClotTriever Catheter to Investigate Safety and Effectiveness in the Treatment of Acute and Subacute Iliofemoral Deep Vein Thrombosis (DVT)

Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis

NCT04411316 ·Status: WITHDRAWN ·Phase: PHASE4

ClotTriever Outcomes (CLOUT) Registry

NCT03575364 ·Status: COMPLETED

Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism

NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Second Line Endovascular Treatment in Acute DVT

NCT06486181 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Deep Venous Thrombosis and Long Term Complications

NCT05789108 ·Status: RECRUITING ·Phase: NA

Treatment for Blood Clots in the Veins of the Legs

NCT00001713 ·Status: COMPLETED ·Phase: PHASE1

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

NCT01285661 ·Status: COMPLETED ·Phase: PHASE3

Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome

NCT04597138 ·Status: COMPLETED

A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

NCT00451412 ·Status: COMPLETED ·Phase: PHASE3

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

NCT05795062 ·Status: COMPLETED

AI-Based Prediction Model for Iliofemoral DVT Thrombolysis

NCT07181083 ·Status: ACTIVE_NOT_RECRUITING

DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.

NCT00970619 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries.

NCT04608591 ·Status: UNKNOWN

Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)

NCT00067093 ·Status: COMPLETED ·Phase: PHASE3

Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis

NCT04670432 ·Status: COMPLETED ·Phase: PHASE3

Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication

NCT01805544 ·Status: COMPLETED

Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis

NCT02078154 ·Status: TERMINATED

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

NCT01523418 ·Status: WITHDRAWN

Risk Factors for Venous Thromboembolism in the Community

NCT00011180 ·Status: COMPLETED

Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT

NCT04297787 ·Status: COMPLETED ·Phase: NA

MDA D-Dimer / Recurrent DVT Study

NCT00157599 ·Status: COMPLETED ·Phase: NA

Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

NCT04833764 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

NCT03465735 ·Status: TERMINATED ·Phase: NA

Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins

NCT00082355 ·Status: COMPLETED ·Phase: PHASE2

Understanding Risk Factors Involved in Developing a Second Blood Clot.

NCT00261014 ·Status: UNKNOWN